-
Cinda anti-CD47/PD-L1 bispecific antibody Phase I clinical completion of China's first patient administration.
Time of Update: 2020-08-05
IBI322 is an anti-CD47/PD-L1 bispecific antibody that blocks both PD-1/PD-L1 and CD47/SIRP-alpha pathways.
-
Cinda BioCD47/PD-L1 B2specific Antibody Phase I Clinical Study completed the first patient administration in China.
Time of Update: 2020-08-05
Cinda Biopharmaceuticals has just announced that its potential lying phase I clinical study of anti-CD47/PD-L1 bispecific antibodies (research code: IBI322) has completed the first patient administration in China.
-
Nature: One inoculation provides near-complete protection, and the results of the Johnson and Johnson's new crown vaccine animal experiment sharply.
Time of Update: 2020-08-05
studies have shown that a single dose of vaccine induces a powerful neutralizing antibody response, and after 6 weeks of vaccination, almost all rhesus monkeys are immune to the virus.
-
Last year, China added 2 billion tons of oil fields and 3 billion square-grade natural gas fields.
Time of Update: 2020-08-04
breakthroughs, oil and gas proven reserves have increased significantly. 2019, 2 billion tons of new oil fields, 3 billion square natural gas fields and 3 billion square shale gas fields. data show that oil has added 1.124 billion tons
-
Pioneering Pharmaceuticals completed a Phase Ib clinical trial in the United States for Freythaen (KX-826).
Time of Update: 2020-08-04
Guide: Freythan (KX-826) is used to treat ar antagonic, a small molecule used in androgen alfa. , Which. announced on August 4th that the group had completed a Phase Ib clinical trial in the United States. F. Furitaen (KX-826
-
CRISPR diagnostic enterprise Tolo Hong Kong bio completed tens of millions of yuan of financing, China Da win-win exclusive investment.
Time of Update: 2020-08-04
. (hereinafter referred to as "Tolo Gang Bio") announced that the company has successfully completed tens of millions of yuan of financing, this round of financing will be mainly used for the company CRISPR diagnostic stoic patents - HOLMES technology
-
Mr. Zhang said the outbreak would not stop completely in a year or two, and that a second wave is expected this fall.
Time of Update: 2020-08-04
of when the global outbreak will turn, Says Chamberlain said, and the global epidemic is now divided into several situations: some countries have begun to slow down, such as Italy, Spain and other European countries; Mr. Zhang said
-
"Pharmaceutical Speed Reader" people Fu PharmaceuticalSa-Ylun China was approved deqi medicine to complete the C round of financing.
Time of Update: 2020-08-03
risk area cleared zero. (Beijing epidemic prevention and control press conference) the state sent a strong grass-roots: prohibit higher-level hospitals "siphon-type" to dig up talent recently, the Ministry of Human Resources and Social Security
-
As of 2020/05/28, a complete list of drugs for consistency evaluation has been published.
Time of Update: 2020-08-03
According to the pharmago visual analysis results, a total of 694 drugs (885 acceptance numbers) had passed consistency evaluations as of 2020/5/28.
-
The medical waste inspection is here! The most complete disposal method to know.
Time of Update: 2020-08-03
On April 29, 2020, the Law of the People's Republic of China on the Prevention and Control of Environmental Pollution from Solid Waste was amended and adopted by the 17th Session of the Standing Committee of the 13th National People's Congress
-
The tumor is completely eliminated! CAR-T battle solid tumor again happy news.
Time of Update: 2020-08-03
on the advanced version of HEROS 2.0. in addition to recurrence, in a previous clinical trial of HEROS (NCT00902044), the Hegde team also found that CAR-T cells targeting HER2 were amplified in a child with RMS but did not persist in their body, which
-
The latest and most complete! China's stem cell drug registration declaration summary.
Time of Update: 2020-08-03
as can be seen from figure 3 below, so far, a total of 10 of the 25 stem cell drug declared varieties received in China have been approved or licensed for clinical trials, with an approval rate of 40%.
-
Health management map decryption: 3 years more than 100 investment three major track billions of dollars.
Time of Update: 2020-08-03
, the maturity of technology and products, often means that "standard, replicable, scaleable, quantifiable" logic sitting solid, a "long and wide track" has emerged. , a group of investors with business cards and capital began to look for cases
-
The lowest price of more than 3 billion varieties is refreshed.
Time of Update: 2020-08-03
Recently, Shaanxi Province Public Resources Trading Center issued "newly approved drug-related information", Cinda Bio's Beval zhu sing-net price was announced, the price of 1188 yuan / bottle (4ml: 100mg).
-
Just! Local health insurance 3 years to withdraw the variety announced.
Time of Update: 2020-08-03
in "Publicity", Chongqing City issued the local supplement of the three-year digestion principle of health insurance Class B drugs: .
-
After the "3-21" explosion in the water, many provinces and cities urgently requested to check the hidden dangers of dangerous chemicals.
Time of Update: 2020-08-02
, asking that General Secretary Xi Jinping to earnestly implement the spirit of Jiangsu Zhongshui Tian Jiayi Chemical Co., Ltd. "3-21" explosion accident important instructions, on further do a good job in the current safety of production, resolutely
-
Innovative cell therapy FCR001 completed the first live kidney transplant in Phase 3 clinical lysa.
Time of Update: 2020-08-02
Turn from . . . On July 22nd Talaris Therapeutics announced that it had completed the first live kidney transplant (LDKT) in a phase 3 clinical trial called FREEDOM-1 in cell therapy FCR001, which is designed to assess the safety and effectiveness
-
"Pharmaceutical Speed Reader" mRNA vaccine start phase 3 clinical multi-drug recommended by the European Union approval.
Time of Update: 2020-08-02
in the Priority Review; AstraZeneca Calquence has been approved by the European Union for the treatment of adult Patients with CLL... Daily fresh medicine to hear medical news, fast-reading society with you to pay attention! Part 1 Policy Brief July 27
-
Health insurance fund to guide the reform of the pharmaceutical supply side to completely
Time of Update: 2020-08-02
the medical insurance fund strong supervision system and strict law enforcement system, to achieve the medical insurance fund supervision and rule of law, specialization, standardization, normalization, and in social practice and supply-side reform
-
Non-plague epidemic area 3 km negative pig farm can not be culled, the epidemic point after unsealing the fastest 75 days can also raise pigs,
Time of Update: 2020-08-02
of course is to stop the spread and spread of African swine fever, but as a common pig common people, I good pig, not on behalf of my pigs are okay, 3 kilometers as long as there are pigs infected with African swine fever, I also have no remaining
